Health Agencies Review Vitamin D Safety Standards, Online Rules

Health agencies and legal experts are reviewing Vitamin D safety standards and online promotion rules to prevent severe toxicity from incorrect dosing.

The public health code separates dietary supplements from prescription medications. Substances with curative or preventative properties are classified as drugs. These require a prescription and pharmacist distribution.

Food supplements fall under food law when sold in capsules, tablets, or liquid droppers. These products must not make therapeutic claims.

The Agence nationale de sécurité du médicament and Anses previously warned about hypercalcemia in young children. They linked these cases to vitamin D-enriched food supplements. Investigations found instances where people bought drops online as substitutes for prescribed medication.

Excessive vitamin D intake causes high blood levels, according to the Office of Dietary Supplements. Daily limits for total intake scale by age.

Infants aged birth to 6 months face a limit of 25 mcg or 1,000 IU. Infants aged 7 to 12 months reach 38 mcg or 1,500 IU.

Children aged 1 to 3 years have an upper limit of 63 mcg. This rises to 75 mcg for ages 4 to 8. People aged 9 and older, including pregnant and breastfeeding women, have a limit of 100 mcg, according to the Office of Dietary Supplements.

Digital content creators face strict advertising boundaries. French commercial influence legislation requires creators to disclose promotional partnerships.

Health rules prohibit advertising for medications. They also restrict endorsements that direct people to commercial purchase links.

The Agence nationale de sécurité du médicament (ANSM) serves as the primary French drug regulator, tasked with assessing the safety, efficacy, and quality of medical products throughout their life-cycle. Since May 1, 2012, when the agency superseded the tasks and duties of its predecessor, it has held the authority to balance patient safety with access to therapies.

This regulatory mandate includes monitoring risks associated with pharmaceutical products, providing the agency with the oversight necessary to enforce safety standards for high-dose vitamin D formulations that fall under its classification of drugs.

The public drug database lists cholecalciferol drinkable ampoules containing 50,000, 80,000, 100,000, or 200,000 IU. These items remain on specific prescription lists. It is not yet known how authorities will enforce these standards across international e-commerce platforms.

Photo of author

Health Desk

Health Desk at Archyde.

Microsoft Develops New Xbox Generation to Bridge Console and PC Gaming

Treasury Secretary Scott Bessent Declines to Support Jensen Huang’s Return as Nvidia CEO